Alpertine

This classification denotes an antipsychotic agent with the molecular formula C25H31N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KYT38QTB4K, chemically known as 1h-indole-2-carboxylic acid, 5,6-dimethoxy-3-(2-(4-phenyl-1-piperazinyl)ethyl)-,ethyl ester but generally known as alpertine, which bears US NIH Compound Identifier 166547. European Medicines Agency schedules Alpertine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05362MIG. The term ALPERTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). Most nations schedule alpertine under HS 29335995 and SITC 51576. As of Q4 2014, ALPERTINE remains the US FDA Preferred Term for this commodity. Alpertine bears US NLM identifiers UMLS ID C2348431 and NCI Concept Code C73300. SMILES: O(C(=O)C1[NH]C2C(C1CCN1CCN(CC1)C1CCCCC1)CC(OC)C(OC)C2)CC.